Publications
5802 Results
- Journal / Conference
- Journal of Clinical Oncology Dec 20;39(36):4009-4019. doi: 10.1200/JCO.21.02008. Epub 2021 Nov 9
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34752136
- PMC
- PMC8677996
- Study Number(s)
- CTSU/C80702
Early-Onset Colorectal Adenocarcinoma in the IDEA database: Treatment Adherence, Toxicities and Outcomes with 3 and 6 months of Adjuvant Fluoropyrimidine and Oxaliplatin
- Journal / Conference
- Global Research Network-American Society of Human Genetics (PGRN-ASHG) Symposium (October 8, 2021), poster
- Year
- 2021
Survey of U.S. Medical Oncologists’ Practices and Beliefs regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy
- Journal / Conference
- Clinical Cancer Research Dec 29. doi: 10.1158/1078-0432.CCR-21-2389. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34965954
- Study Number(s)
- CTSU/C80405
Plasma protein biomarkers predictive of benefit from bevacizumab versus cetuximab in colorectal cancer: Results from CALGB 80405 (Alliance)
- Journal / Conference
- Cancer Feb 15;127(4):639-647
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID33136296
- PMC
- PMC7854890
Caregiver engagement practices in National Cancer Institute Clinical Oncology Research Program settings: Implications for research to advance the field
- Journal / Conference
- Translational Andrology and Urology Oct;10(10):4075-4084
- Year
- 2021
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID34804849
- PMC
- PMC8575592
- Study Number(s)
- S1823
Narrative review of developing new biomarkers for decision making in advanced testis cancer [Review]
- Journal / Conference
- European Urology Apr;79(4):437-439
- Year
- 2021
- Research Committee(s)
- Genitourinary
- PMID
- PMID33454163
- Study Number(s)
- S1602, SWOG-8507
The Who, What, When, Where, and Why of Bacillus Calmette-Guérin-unresponsive Bladder Cancer [Editorial]
- Journal / Conference
- Leukemia Research Dec;111:106736
- Year
- 2021
- Research Committee(s)
- Leukemia
- PMID
- PMID34773794
- PMC
- PMC8643322
- Study Number(s)
- CTSU/E2902
Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial
- Journal / Conference
- Journal of Clinical Oncology, Nov 10;39(32):3574-3582
- Year
- 2021
- Research Committee(s)
- Breast
- PMID
- PMID34406870
- PMC
- PMC8577682
- Study Number(s)
- CTSU/R9804
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804
- Journal / Conference
- JCO Clinical Cancer Informatics Apr;5:414-420
- Year
- 2021
- Research Committee(s)
- Melanoma
- PMID
- PMID33830787
- PMC
- PMC8240789
- Study Number(s)
- S0438, S0512
Accounting for All Patients in Waterfall Plots
- Journal / Conference
- Urologic Oncology (Seminars and Original Investigations) Jul;39(7):435.e17-435.e22
- Year
- 2021
- Research Committee(s)
- Genitourinary
- PMID
- PMID33436327
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)